Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >PF-06821497
PF-06821497
  • PF-06821497

PF-06821497 NEW

Price $97 $239 $372
Package 1mg 5mg 10mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-19

Product Details

Product Name: PF-06821497 CAS No.: 1844849-10-0
Purity: 97.88% Supply Ability: 10g
Release date: 2024/11/19

Product Introduction

Bioactivity

NamePF-06821497
DescriptionPF-06821497 is a selective inhibitor of EZH2 with significant tumor growth inhibition.
In vitroMETHODS: U251 cells were treated with PF-06821497 (0, 50, 100 μM) and ONC201 (0, 5 μM), and cleaved PARP (clvd-PARP) and cleaved caspase 3 were analyzed by immunoblotting. RESULTS Combination treatment of PF-06821497 and ONC201 also induced more cleaved PARP in U251 cells and promoted cancer cell apoptosis. [2]
In vivoMETHODS: Mice bearing Karpas-422 DLBCL tumor xenografts (containing the Y641N EZH2 mutation) were treated with PF-06821497 (100,300 mg/kg, PO, twice daily) and tumor growth was observed in the mice. RESULTS Low-dose PF-06821497 can significantly inhibit tumor growth, while high-dose PF-06821497 can cause tumor regression with minimal impact on animal body weight. [1]
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationDMSO : 55 mg/mL (117.69 mM)
KeywordsPF-06821497 | PF06821497 | PF 06821497
Inhibitors RelatedBIX-01294 trihydrochloride | Tazemetostat | Piribedil | XY1 | UNC 0631 | GSK126 | MAK683 | EZM 2302 | EPZ015666 | AMI-1 free acid | MS37452 | MRTX-1719
Related Compound LibrariesAnti-Lung Cancer Compound Library | Histone Modification Compound Library | Bioactive Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/10g
VIP3Y
HangZhou RunYan Pharma Technology Co.,LTD.
2024-09-20
$0.00/1G
VIP4Y
Wuhan Nutra Biotechnology Co.,Ltd
2022-05-28
$0.00/1gram
VIP3Y
Wuhan Senwayer Century Chemical Co.,Ltd
2022-12-08
$97.00/1mg
VIP3Y
TargetMol Chemicals Inc.
2024-11-19
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hills
INQUIRY